Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease
These guidelines are presented as a follow-up to the original Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of infliximab in Crohn's disease, published in the Canadian Journal of Gastroenterology (1). The original guidelines represented publications between...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2004-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2004/670161 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549593728942080 |
|---|---|
| author | Remo Panaccione Richard N Fedorak Guy Anmais Charles N Bernstein Alain Bitton Ken Croitoru Robert Enns Brian Feagan Marty Fishman Gordon Greenberg Anne Griffiths John K Marshall Imran Rasul Daniel Sadowski Ernest Seidman Hillary Steinhart Lloyd Sutherland Eric Walli Gary Wild C Noel Williams Mary Zachos |
| author_facet | Remo Panaccione Richard N Fedorak Guy Anmais Charles N Bernstein Alain Bitton Ken Croitoru Robert Enns Brian Feagan Marty Fishman Gordon Greenberg Anne Griffiths John K Marshall Imran Rasul Daniel Sadowski Ernest Seidman Hillary Steinhart Lloyd Sutherland Eric Walli Gary Wild C Noel Williams Mary Zachos |
| author_sort | Remo Panaccione |
| collection | DOAJ |
| description | These guidelines are presented as a follow-up to the original Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of infliximab in Crohn's disease, published in the Canadian Journal of Gastroenterology (1). The original guidelines represented publications between 1998 and 2000. The current guidelines have been updated to reflect knowledge gained from two pivotal randomized clinical trails, with the use of infliximab in the maintenance of inflammatory Crohn's disease in remission (2) and in the maintenance of fistulous Crohn's disease in remission (3). |
| format | Article |
| id | doaj-art-8c23acbed7c149cfaa362f5b3a0fe2f3 |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2004-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-8c23acbed7c149cfaa362f5b3a0fe2f32025-02-03T06:10:58ZengWileyCanadian Journal of Gastroenterology0835-79002004-01-0118850350810.1155/2004/670161Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's DiseaseRemo Panaccione0Richard N Fedorak1Guy Anmais2Charles N Bernstein3Alain Bitton4Ken Croitoru5Robert Enns6Brian Feagan7Marty Fishman8Gordon Greenberg9Anne Griffiths10John K Marshall11Imran Rasul12Daniel Sadowski13Ernest Seidman14Hillary Steinhart15Lloyd Sutherland16Eric Walli17Gary Wild18C Noel Williams19Mary Zachos20University of Calgary, Calgary, Alberta, CanadaUniversity of Alberta, Edmonton, Alberta, CanadaHôpital Maisonneuve-Rosemont, Montreal, Quebec, CanadaUniversity of Manitoba, Winnipeg, Manitoba, CanadaMcGill University, Montreal, Quebec, CanadaMcMaster University, Hamilton, Ontario, CanadaUniversity of British Columbia, Vancouver, British Columbia, CanadaUniversity of Western Ontario, London, Ontario, CanadaUniversity of British Columbia, Vancouver, British Columbia, CanadaUniversity of Toronto, Toronto, Ontario, CanadaUniversity of Toronto, Toronto, Ontario, CanadaMcMaster University, Hamilton, Ontario, CanadaCredit Valley Hospital, Mississauga, Ontario, CanadaUniversity of Alberta, Edmonton, Alberta, CanadaSt Justine Hospital, Montreal, Quebec, CanadaUniversity of Toronto, Toronto, Ontario, CanadaUniversity of Calgary, Calgary, Alberta, CanadaWinnipeg Clinic, Winnipeg, Manitoba, CanadaMcGill University, Montreal, Quebec, CanadaUniversity of Alberta, Edmonton, Alberta, CanadaUniversity of Toronto, Toronto, Ontario, CanadaThese guidelines are presented as a follow-up to the original Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of infliximab in Crohn's disease, published in the Canadian Journal of Gastroenterology (1). The original guidelines represented publications between 1998 and 2000. The current guidelines have been updated to reflect knowledge gained from two pivotal randomized clinical trails, with the use of infliximab in the maintenance of inflammatory Crohn's disease in remission (2) and in the maintenance of fistulous Crohn's disease in remission (3).http://dx.doi.org/10.1155/2004/670161 |
| spellingShingle | Remo Panaccione Richard N Fedorak Guy Anmais Charles N Bernstein Alain Bitton Ken Croitoru Robert Enns Brian Feagan Marty Fishman Gordon Greenberg Anne Griffiths John K Marshall Imran Rasul Daniel Sadowski Ernest Seidman Hillary Steinhart Lloyd Sutherland Eric Walli Gary Wild C Noel Williams Mary Zachos Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease Canadian Journal of Gastroenterology |
| title | Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease |
| title_full | Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease |
| title_fullStr | Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease |
| title_full_unstemmed | Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease |
| title_short | Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease |
| title_sort | canadian association of gastroenterology clinical practice guidelines the use of infliximab in crohn s disease |
| url | http://dx.doi.org/10.1155/2004/670161 |
| work_keys_str_mv | AT remopanaccione canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT richardnfedorak canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT guyanmais canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT charlesnbernstein canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT alainbitton canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT kencroitoru canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT robertenns canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT brianfeagan canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT martyfishman canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT gordongreenberg canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT annegriffiths canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT johnkmarshall canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT imranrasul canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT danielsadowski canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT ernestseidman canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT hillarysteinhart canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT lloydsutherland canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT ericwalli canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT garywild canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT cnoelwilliams canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease AT maryzachos canadianassociationofgastroenterologyclinicalpracticeguidelinestheuseofinfliximabincrohnsdisease |